Trial Profile
Targeting Sympathetic Overactivity in Heart Failure Patients With Statins.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Simvastatin (Primary)
- Indications Heart failure
- Focus Pharmacodynamics
- 26 Jun 2013 Planned number of patients changed from 45 to 30 as reported by ClinicalTrials.gov.
- 26 Jun 2013 Planned End Date changed from 1 Jun 2011 to 1 Jul 2014 as reported by ClinicalTrials.gov.
- 07 Apr 2010 New trial record